Does p53 immunostaining improve diagnostic accuracy in urine cytology?
The frequent change of the transitional cell carcinoma of the urinary tract accounts for the fact that cytological abnormalities in urinary specimens are often not sufficient to enable a definitive diagnosis of malignancy. The purpose of this work was to evaluate the possible use of p53 protein in increasing the diagnostic accuracy of urinary cytology. The expression of p53 was investigated by immunocytochemistry in two groups of urinary specimens, one cytologically positive and the other cytologically negative for cancer. Immunostaining was carried out using a monoclonal antibody to p53. In the positive group, in which bladder cancer was confirmed by cystoscopy and biopsy (31 cases), positive reaction for p53 was found in 55% of the cases (17 cases). In the negative group (92 cases), presence of cancer was histologically ascertained in 64 cases and in this group 15 cases (23.4%) showed positive p53 staining. In the remaining 28 cases of this group, where TCC was not present, 7 cases showed p53 positivity in non-neoplastic urothelial cells. This result shows that, while immunocytochemical detection of p53 in urinary specimens may be used for prognostic evaluation of patients with bladder cancer, it does not contribute to the diagnostic accuracy in cases with morphologically inconclusive or negative cytology. The sensitivity and specificity of the method in detecting bladder carcinoma were 23.5 and 75%, respectively.
Righi
E
E
Department of Morphological Sciences and Legal Medicine, University of Modena, Italy.
Rossi
G
G
Ferrari
G
G
Dotti
A
A
De Gaetani
C
C
Ferrari
P
P
Trentini
G P
GP
D015415:Biomarkers / Q000652:urine; D003581:Cytodiagnosis / Q000592:standards*; D006801:Humans; D007150:Immunohistochemistry; D012680:Sensitivity and Specificity; D016159:Tumor Suppressor Protein p53 / Q000652:urine*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000652:urine
D015415:Biomarkers; D016159:Tumor Suppressor Protein p53